Harbor Capital Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Harbor Capital Advisors's BMY Position: Q2 2026 in Review
Harbor Capital Advisors increased its Bristol-Myers Squibb (BMY) stake by 0.22% in Q2 2026, buying an estimated $172 and bringing the position to 1,390 shares worth $80K. The position accounts for 0.01% of the portfolio, ranked #664.
Harbor Capital Advisors first reported a position in BMY in Q2 2025 and has held it in 5 quarters since. The position peaked at $84K in Q1 2026. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Harbor Capital Advisors held 1,390 shares of Bristol-Myers Squibb worth $80K as of Q2 2026.
- Harbor Capital Advisors bought 3 Bristol-Myers Squibb shares in Q2 2026, an estimated $172.
- Bristol-Myers Squibb made up 0.01% of Harbor Capital Advisors's portfolio in Q2 2026, its #664 holding.
- Harbor Capital Advisors first reported a position in Bristol-Myers Squibb in Q2 2025 and has held it in 5 quarters since.
- Harbor Capital Advisors's Bristol-Myers Squibb position peaked at $84K in Q1 2026.
- 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Harbor Capital Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.